ES
The startup develops cancer and immunoregulatory treatments using a synthetic biology platform that produces functionalized vesicles through proprietary transgene technology. This platform enhances mRNA vaccine efficacy for infectious diseases and offers versatile applications in immunomodulation beyond oncology.
Updated 3 months ago
Funding
$2.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops cancer and immunoregulatory treatments using a synthetic biology platform that produces functionalized vesicles through proprietary transgene technology. This platform enhances mRNA vaccine efficacy for infectious diseases and offers versatile applications in immunomodulation beyond oncology.